Vernalis Email Format
Biotechnology ResearchEngland, United Kingdom201-500 Employees
Vernalis is a mid-sized biotechnology research company based in Cambridge, Cambridgeshire, United Kingdom. It specializes in fragment- and structure-based drug discovery, integrating structural biology, biophysics, assay technology and medicinal chemistry to identify lead compounds and development candidates. The firm works across oncology, neurodegeneration, anti-infectives and inflammation and can advance projects from target identification to a clinical candidate. It has generated lead compounds on kinases, ATPases, protein-protein interactions and GPCRs, including clinical candidates for Chk1, Hsp90, Bcl-2, Mcl-1, FAAH and A2A. In addition to its internal project portfolio, Vernalis engages in collaborations with pharmaceutical companies and academic partners under a shared-risk model.